Sandu Pharmaceuticals informs about resignation of CFO

22 Nov 2023 Evaluate

In compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (LODR) Regulations 2015, Sandu Pharmaceuticals has informed that Rakesh Parekh has tendered his resignation from the Post of Chief Financial Officer (CFO) and KMP of the Company with effect from 31st December 2023 (after the closing of business hours) on account of personal reasons. Further, Rakesh Parekh has also confirmed that there is no other material reason other than mentioned in his resignation letter (attached resignation letter). The details required under Regulation 30 of the SEBI (LODR) Regulation 2015 read with SEBI Circular No CIR/CFD/CMD/4/2015 dated September 9,2015 are given in the enclosed Annexure I. The Company is in the process of appointing a new Chief Financial Officer and the same will be communicated to the Stock Exchange in due course.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

61.75 -1.24 (-1.97%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.